/

Sociétés

AM

Sociétés

AMSBIOPHARMA

Ce que nous écrivons

MusiquePharmacieSantéSanté PubliqueUniversité

39 communiqués de presse

Voir tous les communiqués de presse

Press Release cover image

12/06/2026

Santé

Santé Publique

HCP detection in biologics: LC-MS/MS strategies | AMSbiopharma

Source

1.00

0

Press Release cover image

19/05/2026

Musique

Santé

Santé Publique

ICH Q11 drug substance development strategies | AMSbiopharma

Source

1.00

0

Press Release cover image

13/05/2026

Santé

Pharmacie

Santé Publique

ICH Q8 pharmaceutical development and QbD strategies | AMSbiopharma

Source

1.00

0

Press Release cover image

29/04/2026

Santé

Santé Publique

Peptide purification methods in drug development | AMSbiopharma

Source

1.00

0

Press Release cover image

16/04/2026

Santé

Santé Publique

Metabolomics and lipidomics in drug development | AMSbiopharma

Source

1.00

0

Press Release cover image

24/03/2026

Université

Santé

Santé Publique

Drug development timeline and regulatory delays | AMSbiopharma

Source

1.00

0

Press Release cover image

11/03/2026

Musique

Santé

Santé Publique

CMC in the drug development process and IND analytical strategy | AMSbiopharma

Source

1.00

0

Press Release cover image

26/02/2026

Santé

Santé Publique

Gene and cell therapy analytical strategies and compliance | AMSbiopharma

Source

1.00

0

Press Release cover image

19/02/2026

Santé

Pharmacie

Santé Publique

EMA nitrosamines update and acceptable intake limits | AMSbiopharma

Source

1.00

0

Press Release cover image

05/02/2026

Santé

Santé Publique

Fit-for-purpose QC protocols for nucleic acid therapeutics | AMSbiopharma

Source

1.00

0

Followers

0

Compatibilité

0